Innovatus Life Sciences Acquisition Corp. (ILAC)
Innovatus Life Sciences Acquisition will go public soon, but the exact IPO date is still unknown.
Stock Price: $10.00
Confirmed IPO price
Chart not available yet
Data will show when the stock starts trading.
| Market Cap | 224.60M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 22.46M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | n/a |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About ILAC
Innovatus Life Sciences Acquisition Corp. is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We intend to initially focus our search on identifying a prospective target business in the life sciences sector. Our sponsor is an affiliate of Innovatus Capital Partners, LLC, a boutique private equity firm with 27 professionals focused on creating value in special situations, growth equity, emergin... [Read more...]
Industry
Blank Check / SPAC
Founded
2021
CEO
David Schiff
Country
United States
Stock Exchange
NASDAQ
Ticker Symbol
ILAC
News
Innovatus Life Sciences Acquisition IPO Registration Document (S-1)
Innovatus Life Sciences Acquisition Corp. has filed to go public with an IPO on the NASDAQ.